The diagnosis of asymptomatic deep venous thrombosis by D-dimer in patients with recurrent gynecologic cancer.

The diagnosis of asymptomatic deep venous thrombosis by D-dimer in patients with recurrent gynecologic cancer. - D-diRec study

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000024141

Enrollment

150

Registered

2016-09-23

Start date

2015-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian cancer

Interventions

Measurement of D-dimer, blood cell count, neutrophil count, platelet count, serum CRP value. Ultra-sonography of deep vein of leg (if D-dimer&gt

1.5mg/mL ) Chest CT scan (if pulmonary thromboembolic disease was suspected)

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Posttreatment women with epithelial ovarian cancer.

Exclusion criteria

Exclusion criteria: Patients with recurrent ovarian cancer.

Design outcomes

Primary

Measure	Time frame
NPV,PPV,sensitivity,and specificity of D-dimer value to detect DVT	—

Secondary

Measure	Time frame
The prevalence rate of DVT in recurrent ovarian cancer. NPV,PPV,sensitivity,and specificity and specificity of white blood cell count, neutrophil count, platelet count, and serum CRP value to detect DVT. Tendency of D-dimer before clinical recurrence.	—

Countries

Japan

Contacts

Public ContactShoji Nagao

Hyogo Cancer Center Gynecologic Oncology

nagao@hp.pref.hyogo.jp078-929-1151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026